CD8A and influenza: As mentioned above, intranasal administration of the synthetic PEG-Pam2Cys to mice led to reduced viral transmission rates following influenza infection, and promoted the development of adaptive immune responses, measured by the induction of influenza A virus-specific CD8+ T cells [14,15].